ABOUT US

Spaceview Market Research is a global market intelligence firm offering a wide range of services including syndicated market reports, consulting, procurement intelligence, and customer research. We operate in layers- exploring opportunities for our customers, deriving insightful information and reworking them with effective strategies to form customers’ expectations a reality. Our satisfied customer base provides us with more reasons to develop a wider product and repair portfolio, taking one step ahead within the digital transformation revolution. Our services cover a broad spectrum of industries including Chemicals & Advanced Materials, Aerospace, Business Services, Finance Services, Healthcare, Consumer Good & Retail, Food & Beverage, Equipment & Machinery, ICT, Electronics & Semiconductor, Manufacturing & Construction, domain. We provide research services at the global, regional as well as country level; key regions include Europe, Asia-Pacific, North America, Middle East & Africa, and South America. We are a trust brand within the research industry with the potential of commissioning complex projects within a brief span of your time with high level of accuracy. At a Spaceview Market Research, we believe in building long term relations with our clients.

OUR APPROACH IS UNIQUE

Vision

To be the most sought-after market research partner through process innovation, global quality standards and unequalled disposition.

Mission

Spaceview Market Research strives to be the premier consulting organization keeping clients at the middle of our business on a foundation of trust and mutual growth. We make sure that our services help clients taking the choice which maximizes their profit and minimizes risks. To this end, we've integrated our efforts by implanting advanced technologies, empowering our people with right training and opportunities.

Values

Integrity: Maintaining consistency altogether means and actions in conducting our business Quality: Striving to take care of the very best standards altogether our products and processes Continuous improvement: Systematic improvement of all our products, processes and services People: Cultivating a conducive environment where individuals can realize their right potential Customer-centric: focus our energies towards understanding and addressing customer expectations

Press Release

Lorem Ipsum is simply dummy text of the printing and typesetting industry.

2021-06-22

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing

2Lorem Ipsum is simply dummy text of the printing and typesetting industry.

2021-06-21

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing

Global Cell Line Development Market: Increasing R&D activities in the pharmaceuticaland biopharmaceutical industry to boost market growth at a healthy CAGR of ~12.5 % during the forecast period of 2021 to 2027 :

2021-06-21

Market Highlights

 

According to Spaceview Market Research analysis, the global cell line development markets expected to register a CAGR of~12.5 from 2021 to 2027 and hold a value of ~USD 10,700million by 2027.

 

The global cell line development market is driven by the increasing R&D in the pharmaceutical and biopharmaceutical industry, focusing on cell line development. According to the National Institutes of Health (NIH), the federal spending on stem cell line research in 2017 was USD 1.58 billion. The developing economies are also contributing to the increasing R&D activities. For instance, the Indian government is supporting cell line development through national funding agencies like the Department of Biotechnology (DBT), the Department of Science and Technology (DST), Indian Council of Medical Research (ICMR).

 

Several market players are dominating the global cell line development market, contributing to a significant market share. The prominent players are involved in organic and inorganic strategies such as agreements, new product development & launches, joint ventures, mergers &acquisitions, and partnerships to sustain their market positions. For instance, in October 2019, ATCC launched a new authentication service that helps researchers easily confirm mouse cell lines’ identity. The service was developed in partnership with the National Institutes for Standards and Technology (NIST). The service demonstrates ATCC’s continued leadership in developing global biological standards.

 

For more info : http://www.spaceviewmarketresearch.com/

 

Regional Analysis

 

Based on region, North America is anticipated to dominate the global cell line development market in the year 20120, owing to the factors such as the growing number of application of cell line development in new treatment pathway for various diseases such as cancer and other neurological disease, well-established healthcare infrastructure, government support to accelerate research in biotechnology and biopharmaceutical industry, and presence of key players in this region involved in product launch, expansion, acquisition & strategic collaborations. For instance, in December 2016, Sartorius GmbH acquired cell line contractor Cellca. The company provides laboratory that will provide room for expansion in the nearby research institutes.

 

On the other hand, Europe is expected to hold the second-largest position in the global cell line development marketing 2020. Key factors attributing to the market growth are the launch of innovative technologies for cell line synthesis, an increase in various researches for cell line development, and initiatives are taken by the government to support the R&D focused on cell line development. For instance, Lonza Company based in Switzerland launched reformulated CHO media. The serum-free media is designed to help therapeutic protein manufacturers achieve higher titers.

 

Asia-Pacific is anticipated to be the fastest-growing regional market over the assessment period due to rapidly improving healthcare infrastructure, increasing demand for monoclonal antibodies to treat various diseases such as myocardial disease and cancer, among others, use of cell line for vaccine development by the companies and government support in regulating biotechnology products in this region.

 

Furthermore, the growth of the market in the rest of the world cell line development market is attributed to the technological advancements in cell line development, and high penetration of advanced healthcare technologies in research organizations focused on cell line development in Saudi Arabia and the UAE. Developing countries such as Brazil, Argentina, and Colombia, among others in Latin America, are also key contributors to the growth of the market.

 

Segmentation

 

The global cell line development market has been segmented into type, product, source and application.

 

By type, market is segmented into primary cell line, hybridism cell line, continuous cell line, recombinant cell line. Recombinant cell line is projected to hold major share in the year 2021, whereas primary cell line is anticipated to be the fastest growing segment during the forecast period. The recombinant cell line consists of recombinant DNA. The advances in rDNA technology offer enzymes, synthetic hormones immunobiological and anti-cancer agents that is contributing to the market growth of this segment. The growing demand for biopharmaceuticals and biosimilars across the globe will also enhance the demand for recombinant cell lines.

 

By product,

1Lorem Ipsum is simply dummy text of the printing and typesetting industry.11

2021-06-20

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing

News & Articles

Gulf Oil partners with Piaggio to launch co-branded lubricants for CV

APRIL 4, 2020

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less

Gulf Oil partners with Piaggio to launch co-branded lubricants for CV

APRIL 4, 2020

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less

Gulf Oil partners with Piaggio to launch co-branded lubricants for CV

APRIL 4, 2020

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less

Gulf Oil partners with Piaggio to launch co-branded lubricants for CV

APRIL 4, 2020

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less

l